CORRECTED-UPDATE 4-Lilly's drug for Alzheimer's fails big trial; shares drop
Nov 23 (Reuters) - Eli Lilly and Co said its
experimental Alzheimer's treatment failed to slow the loss of
mental functioning in patients with mild symptoms, a major
setback for the company and...
Read more »